At Immunyo we believe that access to innovative health care is a right and not a luxury. We make advanced, state-of-the-art cancer treatments available for patients located all over the world. This innovative and non-invasive approach was awarded with the Nobel Prize in Medicine in 2011.
Immunotherapy with Dendritic Cells (DCT) for cancer patients is barely invasive and pain-free. It uses the body’s immune system, has almost no side-effects, and is appropriate for almost all cancer patients, making it a really versatile treatment option that is now more cost effectiv than other treatments.
It is barely invasive and pain free.
Providing you with a safer alternative to traditional cancer treatments such as chemotherapy, radiation, and surgery.
It utilizes the body’s immune system.
Allowing the treatment to target cancer cells more specifically and effectively than external treatments alone.
There are almost no side effects.
Reducing the potential for additional health complications for cancer patients.
It can be used in combination with other cancer treatments.
Allowing the treatment to target cancer cells more specifically and effectively than external treatments alone.
At Immunyo we believe that access to innovative health care is a right and not a luxury. We make advanced, state-of-the-art cancer treatments available for patients located all over the world. This innovative and non-invasive approach was awarded with the Nobel Prize in Medicine in 2011.
This is a groundbreaking cancer treatment that has revolutionized the field of adaptive immunity. While dendritic cells were discovered more than a century ago, it was only recently that we fully understood their potential in detecting and eliminating cancer cells in the body. Thanks to the pioneering work of Ralph M. Steinman, who was awarded the Nobel Prize in Medicine for his findings, we now have a better understanding of how these cells can be harnessed to fight cancer. With Dendritic Cell Therapy, we are able to prime the cells with the patient’s specific cancer information. The function of dendritic cells is to transmit this information to the B- and T-cells, allowing them to more effectively target and eliminate malignant cells. Therfore, dendritic cells can be defined the guardians of the human body, as their function is to detect invaders likes tumour cells and instruct the immune system to fight them. As mentioned before, these guardians of our body have the ability to instruct all other immune cells to find and eliminate tumour cells, thus empowering the adaptive immunity of the cancer patient.
Immunyo is one of the most competitive medical service providers on the market. Indeed, the Immunotherapy with Dendritic Cells is available from only €18.950. Nevertheless, our patients get access to the most advanced techniques available on the market. Apply for the treatment today, to sooner you start, the better results you can expect.
The Dendritic Cell Therapy protocol at the laboratory encompasses six distinct stages. Initially, monocytes are isolated from the blood and subsequently differentiated into dendritic cells. These dendritic cells are then primed with tailored information regarding the specific cancer type of each patient. Lastly, the immune cells are instructed to discern and eradicate the cancer cells.
Patients from all over world can apply for Immunyo’s DCT.
The treatment can be done in one of our associated clinics in Europe.
Furthermore, if you prefer the comfort of your own home, we can send a medical team to the place of your preference. For extra services we will send you a personalized offer.
Apply now to check your eligibility.
REGISTERED ADDRESS:
160 Collins Avenue East
Dublin 5, D05 E622
Dublin
Ireland
